Ryoji Ichijima

Seven-day vonoprazan and low-dose amoxicillin dual therapy as first-line <i>Helicobacter pylori</i> treatment: a multicentre randomised trial in Japan

Sho Suzuki, Takuji Gotoda, Chika Kusano et al. · Gut · 2020 · 231 citations · Full text

Pharmacy, Pharmacology, Pharmacotherapy +13

Clinical impact of vonoprazan-based dual therapy with amoxicillin for H. pylori infection in a treatment-naïve cohort of junior high school students in Japan

Takuji Gotoda, Chika Kusano, Sho Suzuki et al. · Journal of Gastroenterology · 2020 · 75 citations

Pharmacy, Pharmacology, Pharmacotherapy +8

Lower impact of vonoprazan–amoxicillin dual therapy on gut microbiota for<i>Helicobacter pylori</i>eradication

Toshiki Horii, Sho Suzuki, Chika Takano et al. · Journal of Gastroenterology and Hepatology · 2021 · 44 citations

Life Sciences, Microbiology, Pharmacology +17

Impact of body size on first‐line <i>Helicobacter pylori</i> eradication success using vonoprazan and amoxicillin dual therapy

Hiroyuki Eto, Sho Suzuki, Chika Kusano et al. · Helicobacter · 2021 · 41 citations

Medicine, Pharmacology, Pharmacotherapy +15

Randomized controlled trial comparing conventional and traction endoscopic submucosal dissection for early colon tumor (<scp>CONNECT‐C</scp> trial)

Ryoji Ichijima, Hisatomo Ikehara, Yorinobu Sumida et al. · Digestive Endoscopy · 2022 · 31 citations

Medicine, Oncology, Surgery +12